Abstract
BackgroundThe first etanercept biosimilar was approved by the European Commission in January 2016. Of the 27,000 patients* estimated to be treated with etanercept biosimilar in the Europe, 5,122 patients* are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have